Daniel M. Junius

CIK: 0001094159

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)1 (11.1%)

Position reduction

Option Exercises (M)4 (44.4%)

Derivative conversions

Awards (A)4 (44.4%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

IDXX

IDEXX LABORATORIES INC /DE

Director

Discretionary Trading P&L

Holdings

Transaction History (9 total)

IDXX
IDEXX LABORATORIES INC /DE
May 12, 2026
Award(A)
Non-Qualified Stock Option (right-to-buy)
Direct
525 shares-
IDXX
IDEXX LABORATORIES INC /DE
May 12, 2026
Award(A)
Restricted Stock Unit
Direct
234 shares-
IDXX
IDEXX LABORATORIES INC /DE
May 7, 2026
Exercise(M)
Direct
257 shares-
IDXX
IDEXX LABORATORIES INC /DE
May 13, 2025
Sale(S)
Direct
2.7K shares at avg. $506.41$1.4M
IDXX
IDEXX LABORATORIES INC /DE
May 13, 2025
Exercise(M)
Direct
1.3K shares at avg. $283.59$363K
IDXX
IDEXX LABORATORIES INC /DE
May 13, 2025
Exercise(M)
Direct
1.4K shares at avg. $245.79$345K
IDXX
IDEXX LABORATORIES INC /DE
May 7, 2025
Award(A)
Non-Qualified Stock Option (right-to-buy)
Direct
600 shares-
IDXX
IDEXX LABORATORIES INC /DE
May 7, 2025
Award(A)
Restricted Stock Unit
Direct
257 shares-
IDXX
IDEXX LABORATORIES INC /DE
May 6, 2025
Exercise(M)
Direct
262 shares-

		Type	Shares	Price		Ownership
May 12, 2026	IDXX IDEXX LABORATORIES INC /DE	Award(A) Non-Qualified Stock Option (right-to-buy)	525	-	-	Direct
May 12, 2026	IDXX IDEXX LABORATORIES INC /DE	Award(A) Restricted Stock Unit	234	-	-	Direct
May 7, 2026	IDXX IDEXX LABORATORIES INC /DE	Exercise(M)	257	-	$0	Direct
May 13, 2025	IDXX IDEXX LABORATORIES INC /DE	Sale(S)	2,683	$506.41	$1,358,697	Direct
May 13, 2025	IDXX IDEXX LABORATORIES INC /DE	Exercise(M)	1,279	$283.59	$362,712	Direct
May 13, 2025	IDXX IDEXX LABORATORIES INC /DE	Exercise(M)	1,404	$245.79	$345,089	Direct
May 7, 2025	IDXX IDEXX LABORATORIES INC /DE	Award(A) Non-Qualified Stock Option (right-to-buy)	600	-	-	Direct
May 7, 2025	IDXX IDEXX LABORATORIES INC /DE	Award(A) Restricted Stock Unit	257	-	-	Direct
May 6, 2025	IDXX IDEXX LABORATORIES INC /DE	Exercise(M)	262	-	-	Direct

1-9 of 9 transactions

About JUNIUS DANIEL M

JUNIUS DANIEL M (SEC CIK 0001094159) files insider reports with the SEC as Director of IDEXX LABORATORIES INC /DE (IDXX).

Signal8 holds 4 ownership filings by JUNIUS DANIEL M, all Form 4s, filed between May 8, 2025 and May 14, 2026. Those filings report 9 transactions, from May 6, 2025 to May 12, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on JUNIUS DANIEL M's filings is in WESTBROOK, ME.

Recent filings by JUNIUS DANIEL M

May 12, 2026: Grants or awards of IDXX derivative securities (2 lines, Form 4, code A).
May 7, 2026: Option exercise of IDXX shares (Form 4, code M).
May 13, 2025: Open-market sale of IDXX shares (Form 4, code S).
May 13, 2025: Option exercises of IDXX shares (2 lines, Form 4, code M).
May 7, 2025: Grants or awards of IDXX derivative securities (2 lines, Form 4, code A).

Other insiders filing for IDEXX LABORATORIES INC /DE (IDXX)

HOOLEY JOSEPH L, Director
Kingsley Lawrence D, Director
Emerson Andrew, EVP, CFO and Treasurer
FENNELL GEORGE, Executive Vice President
Vandebroek Sophie V., Director
SAMAD SAM, Director

How to read Form 4 transaction codes